Chemical Structure : BI 1015550
CAS No.: 1423719-30-5
Catalog No.: PC-49676Not For Human Use, Lab Use Only.
BI 1015550 (Nerandomilast, VRN024219) is a potent, selective PDE4B inhibitor that preferentially inhibits hydrolysis of cAMP by PDE4B with IC50 of 10 nM, weakly inhibits PDE4A/4C/4D (IC50=248/8700/91 nM, respectively).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $98 | In stock | |
10 mg | $148 | In stock | |
25 mg | $258 | In stock | |
50 mg | $428 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BI 1015550 (Nerandomilast, VRN024219) is a potent, selective PDE4B inhibitor that preferentially inhibits hydrolysis of cAMP by PDE4B with IC50 of 10 nM, weakly inhibits PDE4A/4C/4D (IC50=248/8700/91 nM, respectively).
BI 1015550 displays no significant activity agianst human PDE7A and human PDE3A, and PDE1C, PDE9A, human PDE2A and PDE5 at 10 uM.
BI 1015550 inhibited LPS-induced TNF- α release with an IC50 35 nM in human PBMCs, inhibited phytohemagglutinin P-induced IL-2 release with IC50 of 9 nM.
BI 1015550 completely inhibited LPS-stimulated TNF-α release with an IC50 in rat whole blood, inhibited TNF-α release up to 70–80% with an IC50 of 670 nM human whole blood.
BI 1015550 (0.01, 0.1, and 1 mg/kg, p.o.) inhibited LPS-stimulated TNF-α release in whole blood ex vivo in mice with ED50 of 0.04 mg/kg.
BI 1015550 (0.01, 0.1, and 1 mg/kg, p.o.) inhibited LPS-induced lung neutrophil influx in male Wistar rats with an ED50 of 0.1 mg/kg.
BI 1015550 inhibited α-SMA protein expression of TGF-β-stimulated IPF-LF with an IC50 of 210 nM, showed a synergistic effect in combination with Nintedanib on fibroblast proliferation.
BI 1015550 is a promising oral clinical candidate for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibro-proliferative diseases.
M.Wt | 448.97 | |
Formula | C20H25ClN6O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
[1-({(5R)-2-[4-(5-chloropyrimidin-2-yl)piperidin-1-yl]-5-oxido-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl}amino)cyclobutyl]methanol |
1. Herrmann FE, et al. Front Pharmacol. 2022 Apr 20;13:838449.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright